NASDAQ:REGN - Regeneron Pharmaceuticals Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $721.75
Forecasted Upside: 10.35 %
Number of Analysts: 18
Breakdown:
0 Sell Ratings
4 Hold Ratings
14 Buy Ratings
0 Strong Buy Ratings

^$654.04 As of 12/8/2021 01:00 AM ET

▲ +18.95 (2.98%)

1 month | 3 months | 12 months

Get New Regeneron Pharmaceuticals Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for REGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for REGN

^$721.75

▲ +10.35% Upside Potential

This price target is based on 18 analysts offering 12 month price targets for Regeneron Pharmaceuticals in the last 3 months. The average price target is $721.75, with a high forecast of $850.00 and a low forecast of $565.00. The average price target represents a 10.35% upside from the last price of $654.04.

Secure Silver Stock Play 2022

From Wealthy Millionaire

Here's one of the most secure silver stock plays in 2022.

Current Consensus is Buy

The current consensus among 18 polled investment analysts is to buy stock in Regeneron Pharmaceuticals. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
18 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

6/16/2020

0 strong buy ratings
18 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

9/14/2020

0 strong buy ratings
16 buy ratings
8 hold ratings
0 sell ratings

Ratings as of

12/13/2020

0 strong buy ratings
13 buy ratings
7 hold ratings
0 sell ratings

Ratings as of

3/13/2021

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

6/11/2021

0 strong buy ratings
12 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

9/9/2021

0 strong buy ratings
12 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

11/8/2021

0 strong buy ratings
14 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

12/8/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
12/8/2021	Wells Fargo & Company	Initiated Coverage	Overweight		Low
12/6/2021	The Goldman Sachs Group	Initiated Coverage	Buy	$824.00	Medium
11/19/2021	BMO Capital Markets	Initiated Coverage	Outperform	$780.00	Low
11/10/2021	Cantor Fitzgerald	Boost Price Target	Positive ➝ Overweight	$700.00 ➝ $760.00	Medium
11/5/2021	SVB Leerink	Boost Price Target	Outperform	$798.00 ➝ $850.00	Medium
11/5/2021	Morgan Stanley	Boost Price Target	Equal Weight	$571.00 ➝ $617.00	Low
11/5/2021	Benchmark	Downgrade	Buy ➝ Hold		High
11/5/2021	HC Wainwright	Boost Price Target	Buy	$842.00 ➝ $844.00	Medium
10/26/2021	SVB Leerink	Boost Price Target	Outperform	$785.00 ➝ $798.00	Medium
10/22/2021	HC Wainwright	Boost Price Target	Buy	$831.00 ➝ $842.00	Low
10/12/2021	Morgan Stanley	Lower Price Target	Equal Weight	$606.00 ➝ $571.00	Low
10/4/2021	HC Wainwright	Reiterated Rating	Buy	$831.00	High
9/21/2021	BMO Capital Markets	Boost Price Target	Outperform	$669.00 ➝ $706.00	Low
9/15/2021	Piper Sandler	Boost Price Target	Overweight	$675.00 ➝ $690.00	Low
9/15/2021	Cantor Fitzgerald	Boost Price Target	Overweight	$670.00 ➝ $700.00	Medium
9/15/2021	HC Wainwright	Boost Price Target	Buy	$787.00 ➝ $831.00	Medium
9/9/2021	UBS Group	Initiated Coverage	Buy	$763.00	High
9/7/2021	Morgan Stanley	Boost Price Target	Equal Weight	$576.00 ➝ $606.00	Low
8/23/2021	Benchmark	Boost Price Target	Buy	$636.00 ➝ $727.00	Low
8/20/2021	HC Wainwright	Reiterated Rating	Buy	$787.00	Low
8/6/2021	Barclays	Boost Price Target	Overweight	$675.00 ➝ $705.00	Medium
8/6/2021	SVB Leerink	Boost Price Target	Outperform	$641.00 ➝ $725.00	High
8/6/2021	BMO Capital Markets	Boost Price Target	Outperform	$625.00 ➝ $669.00	High
8/6/2021	Oppenheimer	Boost Price Target	Outperform	$725.00 ➝ $825.00	Medium
8/5/2021	Piper Sandler	Boost Price Target	Overweight	$650.00 ➝ $675.00	High
8/2/2021	HC Wainwright	Boost Price Target	Buy	$729.00 ➝ $741.00	Low
7/23/2021	Royal Bank of Canada	Boost Price Target	Sector Perform	$629.00 ➝ $679.00	Low
7/8/2021	Benchmark	Boost Price Target	Buy	$590.00 ➝ $636.00	Low
6/29/2021	HC Wainwright	Initiated Coverage	Buy	$703.00	Low
5/7/2021	SVB Leerink	Lower Price Target	Outperform	$657.00 ➝ $641.00	Low
5/7/2021	Morgan Stanley	Boost Price Target	Equal Weight	$477.00 ➝ $495.00	Low
4/19/2021	Morgan Stanley	Lower Price Target	Equal Weight	$525.00 ➝ $477.00	Low
4/13/2021	Robert W. Baird	Reiterated Rating	Hold		Low
4/13/2021	Canaccord Genuity	Reiterated Rating	Buy		Low
3/26/2021	SVB Leerink	Boost Price Target	Outperform	$655.00 ➝ $657.00	High
3/24/2021	Canaccord Genuity	Reiterated Rating	Buy		High
2/24/2021	Canaccord Genuity	Reiterated Rating	Buy		Medium
2/23/2021	Credit Suisse Group	Boost Price Target	Outperform	$753.00 ➝ $760.00	High
2/16/2021	Cantor Fitzgerald	Lower Price Target	Overweight	$696.00 ➝ $656.00	Low
2/8/2021	Morgan Stanley	Lower Price Target	Equal Weight	$553.00 ➝ $525.00	Medium
2/8/2021	Credit Suisse Group	Lower Price Target	Outperform	$758.00 ➝ $753.00	Medium
2/8/2021	Cowen	Lower Price Target	Outperform	$684.00 ➝ $565.00	High
2/8/2021	SVB Leerink	Boost Price Target	Outperform	$623.00 ➝ $640.00	High
1/25/2021	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$630.00	Medium
1/19/2021	Morgan Stanley	Boost Price Target	Equal Weight	$527.00 ➝ $553.00	Low
1/14/2021	Smith Barney Citigroup	Boost Price Target		$575.00 ➝ $584.00	Low
1/13/2021	Benchmark	Upgrade	Hold ➝ Buy	$590.00	Medium
1/8/2021	FIX	Upgrade	Neutral ➝ Buy	$635.00 ➝ $575.00	Medium
12/16/2020	Morgan Stanley	Lower Price Target	Equal Weight	$602.00 ➝ $527.00	Low
12/16/2020	Credit Suisse Group	Lower Price Target	Outperform	$737.00 ➝ $736.00	Medium
11/9/2020	Morgan Stanley	Lower Price Target	Equal Weight	$609.00 ➝ $602.00	High
11/6/2020	Truist	Boost Price Target		$750.00 ➝ $770.00	Low
11/6/2020	Credit Suisse Group	Lower Price Target	Outperform	$745.00 ➝ $737.00	Low
11/6/2020	SVB Leerink	Boost Price Target	Outperform	$650.00 ➝ $653.00	Low
11/6/2020	BMO Capital Markets	Boost Price Target	Market Perform	$626.00 ➝ $630.00	Low
10/13/2020	Morgan Stanley	Lower Price Target	Equal Weight	$611.00 ➝ $609.00	Low
10/6/2020	SVB Leerink	Boost Price Target	Outperform	$629.00 ➝ $650.00	High
10/5/2020	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$690.00	High
10/1/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		High
8/20/2020	Benchmark	Downgrade	Buy ➝ Hold		High
8/7/2020	Credit Suisse Group	Boost Price Target	Outperform	$716.00 ➝ $725.00	Low
8/6/2020	Barclays	Boost Price Target		$615.00 ➝ $675.00	Low
8/6/2020	Morgan Stanley	Lower Price Target	Equal Weight	$619.00 ➝ $611.00	Low
8/6/2020	Oppenheimer	Boost Price Target	Outperform	$675.00 ➝ $725.00	Low
8/6/2020	Citigroup	Boost Price Target	Neutral	$585.00 ➝ $635.00	Low
8/6/2020	BMO Capital Markets	Boost Price Target	Outperform	$525.00 ➝ $626.00	Low
8/5/2020	The Goldman Sachs Group	Boost Price Target		$700.00 ➝ $800.00	Low
8/5/2020	Piper Sandler	Boost Price Target	Overweight	$630.00 ➝ $675.00	High
7/20/2020	Credit Suisse Group	Boost Price Target	Outperform	$700.00 ➝ $716.00	High
7/15/2020	Morgan Stanley	Boost Price Target	Equal Weight	$555.00 ➝ $619.00	Low
7/8/2020	SunTrust Banks	Upgrade	Hold ➝ Buy	$400.00 ➝ $750.00	Low
7/8/2020	Canaccord Genuity	Boost Price Target	Buy	$600.00 ➝ $700.00	Low
7/1/2020	Oppenheimer	Boost Price Target	Outperform	$625.00 ➝ $675.00	High
6/24/2020	Credit Suisse Group	Boost Price Target	Outperform	$605.00 ➝ $700.00	High
6/12/2020	Jefferies Financial Group	Boost Price Target	Buy	$657.00 ➝ $691.00	High
6/2/2020	Jefferies Financial Group	Reiterated Rating	Buy	$657.00	Low
6/2/2020	Cowen	Reiterated Rating	Hold	$584.00	Low
6/2/2020	Oppenheimer	Reiterated Rating	Buy	$625.00	Low
6/2/2020	Cantor Fitzgerald	Boost Price Target	Neutral	$400.00 ➝ $624.00	Low
5/28/2020	Barclays	Boost Price Target		$530.00 ➝ $615.00	High
5/27/2020	Cfra	Lower Price Target	Hold	$557.00 ➝ $549.00	Low
5/27/2020	SVB Leerink	Boost Price Target	Outperform	$622.00 ➝ $625.00	High
5/26/2020	SVB Leerink	Reiterated Rating	Buy	$622.00	Low
5/26/2020	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$559.00 ➝ $734.00	High
5/6/2020	Robert W. Baird	Boost Price Target	Neutral ➝ Neutral	$487.00 ➝ $510.00	High
5/6/2020	Canaccord Genuity	Boost Price Target	Buy	$575.00 ➝ $630.00	High
5/6/2020	BMO Capital Markets	Boost Price Target	Market Perform	$466.00 ➝ $525.00	High
5/6/2020	Royal Bank of Canada	Lower Price Target		$533.00 ➝ $524.00	Medium
5/6/2020	Piper Sandler	Boost Price Target		$550.00 ➝ $600.00	Low
5/6/2020	Morgan Stanley	Boost Price Target	Equal Weight	$409.00 ➝ $555.00	Medium
5/6/2020	Oppenheimer	Boost Price Target	Outperform	$525.00 ➝ $625.00	High
5/6/2020	Credit Suisse Group	Boost Price Target	Outperform	$596.00 ➝ $605.00	High
5/6/2020	The Goldman Sachs Group	Boost Price Target	Conviction-Buy	$636.00 ➝ $700.00	High
5/6/2020	SVB Leerink	Boost Price Target	Outperform	$604.00 ➝ $622.00	High
5/1/2020	Piper Sandler	Reiterated Rating	Overweight		Low
4/28/2020	Canaccord Genuity	Boost Price Target	Buy	$550.00 ➝ $575.00	Medium
4/28/2020	Citigroup	Downgrade	Buy ➝ Neutral	$540.00 ➝ $575.00	High
4/19/2020	Benchmark	Initiated Coverage	Hold		Low
4/17/2020	BMO Capital Markets	Boost Price Target	Market Perform	$379.00 ➝ $466.00	High
4/17/2020	Benchmark	Upgrade	Hold ➝ Buy	$655.00	High
4/15/2020	Morgan Stanley	Lower Price Target	Equal Weight	$410.00 ➝ $409.00	Medium
4/15/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$375.00 ➝ $429.00	Medium
4/8/2020	Benchmark	Initiated Coverage	Hold		Medium
4/7/2020	SVB Leerink	Boost Price Target	Outperform	$600.00 ➝ $604.00	Medium
4/6/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$370.00 ➝ $435.00	Low
3/31/2020	Wolfe Research	Initiated Coverage	Market Perform	$455.00	High
3/12/2020	Argus	Boost Price Target	Buy	$430.00 ➝ $540.00	High
3/11/2020	Oppenheimer	Boost Price Target	Outperform	$450.00 ➝ $525.00	Medium
3/4/2020	Cfra	Boost Price Target	Buy ➝ Hold	$460.00 ➝ $487.00	High
3/4/2020	Piper Sandler	Boost Price Target		$435.00 ➝ $500.00	High
2/28/2020	Cowen	Boost Price Target	Market Perform	$386.00 ➝ $495.00	High
2/28/2020	Citigroup	Boost Price Target	Buy	$420.00 ➝ $540.00	High
2/27/2020	Barclays	Initiated Coverage	Overweight	$530.00	High
2/26/2020	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform	$500.00	Medium
2/26/2020	Credit Suisse Group	Boost Price Target	Top Pick ➝ Outperform	$420.00 ➝ $510.00	High
2/26/2020	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$410.00	High
2/26/2020	Canaccord Genuity	Upgrade	Hold ➝ Buy	$409.00 ➝ $550.00	High
2/25/2020	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$355.00 ➝ $492.00	High
2/24/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform	$500.00	High
2/11/2020	Argus	Upgrade	Hold ➝ Buy	$430.00	Medium
2/7/2020	Evercore ISI	Initiated Coverage	Hold	$400.00	Low
2/7/2020	Morgan Stanley	Lower Price Target	Equal Weight	$411.00 ➝ $410.00	Low
2/7/2020	SunTrust Banks	Boost Price Target	Hold	$400.00	High
1/22/2020	Oppenheimer	Boost Price Target	Outperform	$430.00 ➝ $450.00	Low
1/17/2020	Morgan Stanley	Boost Price Target	Equal Weight	$387.00 ➝ $411.00	Low
1/14/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		High
12/23/2019	Raymond James	Initiated Coverage	Market Perform		N/A
12/13/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$400.00	Low
12/9/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$400.00	Low
11/12/2019	SunTrust Banks	Initiated Coverage	Hold	$360.00	Medium
11/11/2019	Evercore ISI	Reiterated Rating	Buy	$395.00	Low
11/6/2019	Citigroup	Upgrade	Neutral ➝ Buy	$340.00 ➝ $420.00	Low
11/6/2019	Oppenheimer	Lower Price Target		$480.00 ➝ $430.00	Low
11/6/2019	BMO Capital Markets	Boost Price Target	Market Perform	$344.00 ➝ $358.00	Medium
11/6/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$375.00	Medium
11/6/2019	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$310.00 ➝ $340.00	Medium
10/16/2019	Bank of America	Initiated Coverage	Neutral	$325.00	Low
10/9/2019	Canaccord Genuity	Lower Price Target	Hold	$353.00 ➝ $320.00	Medium
10/8/2019	Cowen	Set Price Target	Hold	$349.00	Low
10/8/2019	Piper Jaffray Companies	Set Price Target	Buy	$435.00	Low
10/8/2019	BMO Capital Markets	Set Price Target	Hold	$344.00	Low
9/23/2019	Guggenheim	Upgrade	Neutral ➝ Buy	$355.00 ➝ $403.00	Low
8/7/2019	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$410.00	Low
8/7/2019	Credit Suisse Group	Lower Price Target	Neutral	$333.00 ➝ $325.00	Low
8/7/2019	BMO Capital Markets	Lower Price Target	Market Perform	$344.00	Low
7/29/2019	Cowen	Reiterated Rating	Hold	$353.00	Medium
6/21/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
6/18/2019	Argus	Downgrade	Buy ➝ Hold		High
6/14/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
6/11/2019	SVB Leerink	Set Price Target	Buy	$453.00	Low
5/23/2019	Citigroup	Lower Price Target	Neutral ➝ Neutral	$396.00 ➝ $340.00	Low
5/20/2019	Credit Suisse Group	Initiated Coverage	Neutral	$336.00	High
5/13/2019	Cantor Fitzgerald	Lower Price Target	Neutral	$441.00 ➝ $405.00	Medium
5/8/2019	BMO Capital Markets	Lower Price Target	Positive ➝ Market Perform	$412.00 ➝ $375.00	Medium
5/8/2019	Morgan Stanley	Lower Price Target	Equal Weight	$420.00 ➝ $389.00	Medium
5/8/2019	Canaccord Genuity	Reiterated Rating	Hold ➝ Hold	$408.00 ➝ $353.00	High
5/8/2019	UBS Group	Lower Price Target	Buy	$480.00 ➝ $440.00	Medium
5/7/2019	Piper Jaffray Companies	Reiterated Rating	Overweight	$435.00	Medium
5/7/2019	Cowen	Reiterated Rating	Hold	$353.00	Medium
4/17/2019	Jefferies Financial Group	Lower Price Target	Hold	$376.00 ➝ $343.00	High
2/26/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$487.00	Medium
2/22/2019	Guggenheim	Downgrade	Buy ➝ Neutral	$466.00 ➝ $425.00	Low
2/7/2019	Oppenheimer	Boost Price Target	Outperform	$440.00 ➝ $480.00	Low
2/7/2019	BMO Capital Markets	Boost Price Target	Market Perform	$412.00	Low
2/6/2019	Cantor Fitzgerald	Reiterated Rating	Hold	$441.00	High
1/7/2019	Cowen	Reiterated Rating	Hold	$385.00	Low
1/4/2019	Guggenheim	Upgrade	Neutral ➝ Buy	$461.00	High
12/13/2018	The Goldman Sachs Group	Upgrade	Neutral ➝ Conviction-Buy		Low
12/7/2018	SVB Leerink	Set Price Target	Buy	$473.00 ➝ $483.00	Low
12/2/2018	Oppenheimer	Set Price Target	Buy	$440.00	High
11/13/2018	Argus	Reiterated Rating	Buy		Low
11/7/2018	JPMorgan Chase & Co.	Set Price Target	Hold	$405.00	Medium
11/6/2018	Cowen	Reiterated Rating	Hold	$385.00	Medium
10/22/2018	Cowen	Reiterated Rating	Hold	$385.00	Medium
10/22/2018	Cantor Fitzgerald	Boost Price Target	Neutral	$441.00	Low
10/22/2018	JPMorgan Chase & Co.	Set Price Target	Hold	$405.00	Low
10/11/2018	Morgan Stanley	Boost Price Target	Equal Weight	$409.00 ➝ $412.00	High
10/11/2018	Canaccord Genuity	Boost Price Target	Hold	$390.00 ➝ $410.00	High
10/2/2018	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium
10/1/2018	SVB Leerink	Boost Price Target	Outperform	$506.00 ➝ $512.00	High
10/1/2018	Cantor Fitzgerald	Initiated Coverage	Neutral ➝ Neutral	$415.00	High
8/16/2018	Cowen	Reiterated Rating	Hold	$385.00	Low
8/6/2018	Barclays	Boost Price Target	Underweight ➝ Underweight	$290.00 ➝ $305.00	Low
8/3/2018	Canaccord Genuity	Boost Price Target	Hold ➝ Hold	$304.00 ➝ $390.00	Low
8/3/2018	SunTrust Banks	Reiterated Rating	Hold	$400.00	Low
8/3/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$396.00 ➝ $409.00	Low
8/3/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		Low
8/2/2018	BMO Capital Markets	Set Price Target	Hold	$388.00	Low
7/24/2018	Jefferies Financial Group	Reiterated Rating	Hold	$340.00	Medium
7/19/2018	Canaccord Genuity	Reiterated Rating	$367.74	$304.00	Low
7/16/2018	Argus	Boost Price Target	Buy ➝ Buy	$383.00 ➝ $415.00	Low
7/13/2018	Morgan Stanley	Boost Price Target	Equal Weight	$370.00 ➝ $396.00	Low
7/2/2018	SunTrust Banks	Set Price Target	Hold	$344.00	Low
6/27/2018	Oppenheimer	Upgrade	Market Perform ➝ Outperform	$325.00	High
6/27/2018	UBS Group	Upgrade	Market Perform ➝ Outperform		High
5/23/2018	Barclays	Set Price Target	Sell	$290.00	Low
5/7/2018	Royal Bank of Canada	Lower Price Target	Sector Perform	$342.00	Low
5/5/2018	Credit Suisse Group	Set Price Target	Buy	$420.00	Low
5/4/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$400.00 ➝ $370.00	Low
5/4/2018	Canaccord Genuity	Lower Price Target	Hold ➝ Hold	$356.00 ➝ $304.00	Low
5/4/2018	SVB Leerink	Set Price Target	Buy	$502.00 ➝ $435.00	Low
5/4/2018	BMO Capital Markets	Set Price Target	Market Perform ➝ Hold	$398.00 ➝ $361.00	Low
5/4/2018	Cowen	Reiterated Rating	Outperform	$400.00 ➝ $350.00	Low
5/4/2018	SunTrust Banks	Lower Price Target	Hold	$344.00	Low
5/3/2018	Barclays	Set Price Target	Sell	$290.00	Low
5/1/2018	Guggenheim	Downgrade	Buy ➝ Neutral		Low
4/27/2018	Credit Suisse Group	Set Price Target	Buy	$420.00	High
4/27/2018	Cowen	Reiterated Rating	Hold	$400.00	Low
4/17/2018	Credit Suisse Group	Lower Price Target	Buy	$440.00 ➝ $420.00	Low
4/9/2018	Raymond James	Reiterated Rating	Outperform ➝ Market Perform		Low
4/9/2018	UBS Group	Downgrade	Outperform ➝ Market Perform		Low
3/13/2018	BTIG Research	Reiterated Rating	Hold		Medium
3/13/2018	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$367.00	Medium
2/21/2018	Canaccord Genuity	Downgrade	Buy ➝ Hold	$522.00 ➝ $356.00	Medium
2/13/2018	BTIG Research	Reiterated Rating	Hold		High
2/9/2018	SunTrust Banks	Set Price Target	Hold	$430.00	Low
2/9/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$401.00 ➝ $415.00	High
2/9/2018	SVB Leerink	Lower Price Target	Outperform ➝ Outperform	$568.00 ➝ $502.00	High
2/9/2018	Robert W. Baird	Upgrade	Neutral ➝ Outperform		High
2/9/2018	Guggenheim	Set Price Target	Buy	$530.00	High
2/8/2018	Jefferies Financial Group	Reiterated Rating	Neutral ➝ Hold	$380.00	High
2/8/2018	BTIG Research	Downgrade	Buy ➝ Neutral	$480.00	High
2/8/2018	BMO Capital Markets	Boost Price Target	Market Perform ➝ Market Perform	$398.00 ➝ $444.00	Low
2/7/2018	Credit Suisse Group	Set Price Target	Buy	$440.00	High
2/7/2018	Cowen	Reiterated Rating	Hold	$450.00	High
2/7/2018	Canaccord Genuity	Reiterated Rating	Buy	$522.00	High
2/2/2018	Jefferies Financial Group	Reiterated Rating	Hold	$421.00	Medium
1/24/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$455.00 ➝ $457.00	Low
1/9/2018	Citigroup	Reiterated Rating	Neutral ➝ Neutral	$380.00 ➝ $388.00	High
12/28/2017	Argus	Lower Price Target	Positive ➝ Buy	$540.00 ➝ $470.00	Low
12/14/2017	Royal Bank of Canada	Reiterated Rating	Hold	$430.00	Low
12/12/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$397.00	Medium
12/1/2017	Citigroup	Downgrade	Buy ➝ Neutral	$480.00 ➝ $380.00	High
11/28/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium
11/28/2017	BTIG Research	Lower Price Target	Buy ➝ Buy	$520.00 ➝ $480.00	Low
11/27/2017	BMO Capital Markets	Set Price Target	Hold	$444.00	High
11/22/2017	BTIG Research	Reiterated Rating	Buy	$520.00	Low
11/16/2017	Evercore ISI	Lower Price Target	Outperform	$605.00 ➝ $445.00	N/A
11/13/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$540.00	N/A
11/9/2017	Morgan Stanley	Lower Price Target	Equal Weight	$490.00 ➝ $463.00	N/A
11/9/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform ➝ Sector Perform	$473.00 ➝ $425.00	N/A
11/9/2017	BMO Capital Markets	Lower Price Target	Market Perform	$491.00 ➝ $479.00	N/A
11/9/2017	Citigroup	Reiterated Rating	Buy	$480.00	N/A
11/3/2017	Robert W. Baird	Upgrade	Underperform ➝ Neutral		N/A
10/31/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold		N/A
10/23/2017	Guggenheim	Reiterated Rating	Buy ➝ Buy	$540.00	N/A
10/20/2017	Barclays	Downgrade	Equal Weight ➝ Underweight	$450.00 ➝ $395.00	N/A
10/16/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold		N/A
10/16/2017	Canaccord Genuity	Reiterated Rating	Buy		N/A
10/6/2017	Morgan Stanley	Reiterated Rating	Equal Weight	$450.00 ➝ $490.00	N/A
10/6/2017	Jefferies Financial Group	Reiterated Rating	Hold	$471.00 ➝ $500.00	N/A
10/2/2017	SunTrust Banks	Reiterated Rating	Hold	$435.00	Medium
9/29/2017	Piper Jaffray Companies	Reiterated Rating	Overweight ➝ Overweight	$540.00	High
9/27/2017	Oppenheimer	Reiterated Rating	Hold		Low
9/21/2017	UBS Group	Lower Price Target	Buy	$535.00 ➝ $500.00	Medium
9/14/2017	Royal Bank of Canada	Initiated Coverage	Sector Perform ➝ Sector Perform	$475.00	Medium
9/11/2017	Canaccord Genuity	Reiterated Rating	Buy	$522.00	Low
9/11/2017	Credit Suisse Group	Reiterated Rating	Buy	$485.00	Low
9/8/2017	Robert W. Baird	Reiterated Rating	Sell	$408.00	Low
9/7/2017	Citigroup	Reiterated Rating	Buy	$575.00	Low
9/6/2017	Raymond James	Reiterated Rating	Outperform ➝ Outperform	$566.00	Low
8/23/2017	Morgan Stanley	Reiterated Rating	Equal Weight	$450.00	Low
8/16/2017	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$605.00	Medium
8/15/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
8/15/2017	SVB Leerink	Reiterated Rating	Outperform ➝ Positive	$580.00 ➝ $552.00	Low
8/14/2017	Canaccord Genuity	Set Price Target	Buy	$522.00	Low
8/9/2017	Jefferies Financial Group	Reiterated Rating	Hold	$418.00 ➝ $471.00	Low
8/9/2017	The Goldman Sachs Group	Reiterated Rating	Neutral	$469.00 ➝ $472.00	Low
8/9/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold	$427.00 ➝ $455.00	Low
8/9/2017	SVB Leerink	Reiterated Rating	Outperform	$573.00 ➝ $580.00	Low
8/8/2017	Robert W. Baird	Downgrade	Neutral ➝ Underperform	$408.00	Low
8/4/2017	UBS Group	Reiterated Rating	Buy ➝ Buy	$489.00 ➝ $535.00	Low
8/4/2017	Citigroup	Boost Price Target	Buy	$555.00 ➝ $575.00	Low
8/3/2017	BMO Capital Markets	Set Price Target	Hold	$491.00	Low
8/3/2017	Canaccord Genuity	Set Price Target	Buy	$522.00	Low
8/3/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
8/1/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$557.00	High
8/1/2017	Robert W. Baird	Downgrade	Neutral ➝ Underperform	$408.00	High
7/31/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$484.00	High
7/28/2017	Canaccord Genuity	Set Price Target	Buy ➝ Buy	$484.00 ➝ $522.00	Low
7/22/2017	Barclays	Reiterated Rating	Equal Weight	$400.00 ➝ $450.00	Low
7/21/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$421.00 ➝ $484.00	Low
7/21/2017	Bank of America	Reiterated Rating	Buy	$589.00 ➝ $593.00	Low
7/14/2017	Credit Suisse Group	Downgrade	Hold	$485.00	Low
7/10/2017	Morgan Stanley	Reiterated Rating	Equal Weight	$405.00 ➝ $450.00	Medium
6/30/2017	BTIG Research	Reiterated Rating	Buy ➝ Buy	$480.00 ➝ $540.00	High
6/28/2017	SVB Leerink	Reiterated Rating	Outperform	$493.00 ➝ $573.00	Low
6/26/2017	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform	$410.00 ➝ $480.00	Low
6/22/2017	SVB Leerink	Reiterated Rating	Outperform ➝ Outperform	$573.00	Medium
6/22/2017	Raymond James	Reiterated Rating	Outperform	$475.00 ➝ $547.00	Medium
6/21/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$421.00	Low
6/20/2017	Canaccord Genuity	Set Price Target	Buy	$484.00	Low
6/20/2017	Piper Jaffray Companies	Boost Price Target	Overweight ➝ Overweight	$446.00 ➝ $557.00	Low
6/14/2017	Oppenheimer	Reiterated Rating	Hold		Low
6/13/2017	SVB Leerink	Reiterated Rating	Outperform	$493.00	Low
5/25/2017	Sanford C. Bernstein	Reiterated Rating	Outperform		High
5/15/2017	Credit Suisse Group	Reiterated Rating	Buy	$485.00	Low
5/15/2017	Cowen	Reiterated Rating	Hold	$380.00	Low
5/15/2017	BMO Capital Markets	Boost Price Target	Hold	$412.00 ➝ $421.00	Low
5/8/2017	Barclays	Boost Price Target	Equal Weight	$375.00 ➝ $400.00	Low
5/5/2017	Credit Suisse Group	Reiterated Rating	Buy	$485.00	Low
5/5/2017	UBS Group	Set Price Target	Buy	$446.00 ➝ $489.00	N/A
5/5/2017	Canaccord Genuity	Upgrade	Hold ➝ Buy	$375.00 ➝ $484.00	Low
5/5/2017	Cowen	Reiterated Rating	Hold	$380.00	Low
5/5/2017	BMO Capital Markets	Reiterated Rating	Hold	$412.00 ➝ $421.00	Low
5/4/2017	Oppenheimer	Reiterated Rating	Hold		Low
4/12/2017	Jefferies Financial Group	Reiterated Rating	Hold	$357.00	Low
3/30/2017	Canaccord Genuity	Reiterated Rating	Hold	$375.00	Low
3/29/2017	BTIG Research	Reiterated Rating	Buy	$460.00	Medium
3/29/2017	UBS Group	Boost Price Target	Buy ➝ Buy	$435.00 ➝ $446.00	N/A
3/28/2017	BMO Capital Markets	Reiterated Rating	Hold	$408.00 ➝ $412.00	Low
3/28/2017	SVB Leerink	Set Price Target	Buy	$448.00	Low
3/28/2017	Robert W. Baird	Reiterated Rating	Neutral	$369.00	Low
3/20/2017	SVB Leerink	Reiterated Rating	Outperform		High
3/20/2017	BTIG Research	Reiterated Rating	Buy	$460.00	Low
3/17/2017	Canaccord Genuity	Reiterated Rating	Hold	$375.00	Low
3/17/2017	CIBC	Initiated Coverage	Market Perform ➝ Market Perform		Low
3/16/2017	Oppenheimer	Initiated Coverage	Hold		High
3/9/2017	UBS Group	Initiated Coverage	Buy ➝ Buy	$435.00	N/A
3/8/2017	Piper Jaffray Companies	Set Price Target	Buy	$446.00	Low
2/16/2017	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral		N/A
2/16/2017	Sanford C. Bernstein	Reiterated Rating	Outperform	$420.00 ➝ $410.00	N/A
2/13/2017	Piper Jaffray Companies	Upgrade	Neutral ➝ Overweight	$359.87 ➝ $446.00	N/A
2/11/2017	SVB Leerink	Set Price Target	Buy	$448.00	N/A
2/10/2017	Canaccord Genuity	Reiterated Rating	Hold	$450.00	N/A
2/10/2017	Morgan Stanley	Lower Price Target	Equal Weight	$370.00 ➝ $367.00	N/A
2/10/2017	Citigroup	Reiterated Rating	Buy	$420.00	N/A
2/10/2017	Sanford C. Bernstein	Lower Price Target		$410.00	N/A
2/10/2017	Credit Suisse Group	Reiterated Rating	Buy	$485.00	N/A
2/9/2017	Cowen	Set Price Target	Hold	$380.00	N/A
2/6/2017	The Goldman Sachs Group	Lower Price Target	Buy	$448.00 ➝ $446.00	N/A
2/3/2017	Canaccord Genuity	Set Price Target	Hold	$450.00	N/A
1/22/2017	JPMorgan Chase & Co.	Set Price Target	Hold	$440.00	N/A
1/11/2017	Cowen	Reiterated Rating	Market Perform	$400.00 ➝ $380.00	N/A
1/10/2017	SVB Leerink	Reiterated Rating	Outperform		N/A
1/10/2017	Wells Fargo & Company	Reiterated Rating	Market Perform		N/A
1/9/2017	Morgan Stanley	Set Price Target	Hold	$420.00 ➝ $370.00	N/A
1/8/2017	Evercore ISI	Set Price Target	Hold	$421.00	N/A
1/8/2017	Robert W. Baird	Reiterated Rating	Neutral	$379.00 ➝ $369.00	N/A
1/8/2017	BTIG Research	Reiterated Rating	Buy	$460.00	N/A
1/6/2017	Royal Bank of Canada	Reiterated Rating	Outperform	$626.00 ➝ $598.00	N/A
1/6/2017	Royal Bank of Canada	Lower Price Target	Outperform	$626.00 ➝ $598.00	N/A
1/6/2017	Chardan Capital	Lower Price Target	Neutral	$350.00 ➝ $345.00	N/A
12/28/2016	Argus	Reiterated Rating	Buy	$450.00	N/A
12/20/2016	SVB Leerink	Set Price Target	Buy	$492.00	N/A
12/20/2016	BMO Capital Markets	Initiated Coverage	Market Perform	$419.00	N/A
12/20/2016	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$481.00 ➝ $485.00	N/A
12/16/2016	BTIG Research	Upgrade	Neutral ➝ Buy	$460.00	N/A
12/12/2016	Canaccord Genuity	Set Price Target	Hold	$450.00	N/A
12/12/2016	Robert W. Baird	Reiterated Rating	Positive	$379.00	N/A
12/12/2016	Chardan Capital	Upgrade	Sell ➝ Neutral	$300.00 ➝ $350.00	N/A

(Data available from 12/9/2016 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

0 very positive mentions
12 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

5/13/2021

0 very positive mentions
7 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

6/12/2021

3 very positive mentions
13 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

7/12/2021

11 very positive mentions
22 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

8/11/2021

12 very positive mentions
19 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

9/10/2021

16 very positive mentions
14 positive mentions
4 negative mentions
1 very negative mentions

Mentions as of

10/10/2021

12 very positive mentions
33 positive mentions
1 negative mentions
5 very negative mentions

Mentions as of

11/9/2021

19 very positive mentions
38 positive mentions
12 negative mentions
6 very negative mentions

Mentions as of

12/9/2021

Current Sentiment

Recent Stories by Sentiment

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Today's Range

Now: $654.04

$633.33

$655.75

50 Day Range

MA: $607.60

$543.48

$654.40

52 Week Range

Now: $654.04

$441.00

$686.62

Volume

672,772 shs

Average Volume

844,804 shs

Market Capitalization

$70.34 billion

P/E Ratio

10.44

Dividend Yield

N/A

Beta

0.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Regeneron Pharmaceuticals?: The following equities research analysts have issued stock ratings on Regeneron Pharmaceuticals in the last year: Barclays PLC, Benchmark Co., BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, Cowen Inc, Credit Suisse Group AG, FIX, HC Wainwright, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Robert W. Baird, Royal Bank of Canada, Smith Barney Citigroup, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for REGN.
What is the current price target for Regeneron Pharmaceuticals?: 16 Wall Street analysts have set twelve-month price targets for Regeneron Pharmaceuticals in the last year. Their average twelve-month price target is $721.75, suggesting a possible upside of 10.4%. SVB Leerink LLC has the highest price target set, predicting REGN will reach $850.00 in the next twelve months. Cowen Inc has the lowest price target set, forecasting a price of $565.00 for Regeneron Pharmaceuticals in the next year.
View the latest price targets for REGN.
What is the current consensus analyst rating for Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals currently has 4 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe REGN will outperform the market and that investors should add to their positions of Regeneron Pharmaceuticals.
View the latest ratings for REGN.
What other companies compete with Regeneron Pharmaceuticals?: Other companies that are similar to Regeneron Pharmaceuticals include Amgen, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Seagen, Alnylam Pharmaceuticals, BioMarin Pharmaceutical, Incyte, Exact Sciences, Repligen, Novavax, United Therapeutics, Neurocrine Biosciences, Exelixis and Halozyme Therapeutics.
How do I contact Regeneron Pharmaceuticals' investor relations team?: Regeneron Pharmaceuticals' physical mailing address is 777 OLD SAW MILL RIVER ROAD, TARRYTOWN NY, 10591. The biopharmaceutical company's listed phone number is (914) 847-7000 and its investor relations email address is [email protected] The official website for Regeneron Pharmaceuticals is www.regeneron.com.

Knightscope Kicks Off Public Listing to Trade on NASDAQ

From Start Engine

Knightscope, Inc., a developer of advanced physical security technologies focused on enhancing U.S. security operations, has commenced its offering of up to $40 million of Class A common stock, with shares to be listed immediately following closing on NASDAQ under the ticker symbol “KSCP."

NASDAQ:REGN - Regeneron Pharmaceuticals Stock Price Target and Predictions

Analyst Price Target for REGN

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.32 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Regeneron Pharmaceuticals?

What is the current price target for Regeneron Pharmaceuticals?

What is the current consensus analyst rating for Regeneron Pharmaceuticals?

What other companies compete with Regeneron Pharmaceuticals?

How do I contact Regeneron Pharmaceuticals' investor relations team?